Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-Induced Peripheral Neuropathy Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biofeedback Allen Press

Chemotherapy-Induced Peripheral Neuropathy

,
Biofeedback , Volume 50 (1): 3 – May 31, 2022

Loading next page...
 
/lp/allen-press/chemotherapy-induced-peripheral-neuropathy-f91n0lW62k
Publisher
Allen Press
Copyright
© Association for Applied Psychophysiology & Biofeedback
ISSN
1081-5937
eISSN
2158-348X
DOI
10.5298/1081-5937-50.1.03
Publisher site
See Article on Publisher Site

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.

Journal

BiofeedbackAllen Press

Published: May 31, 2022

There are no references for this article.